Home LiteratureArticle Details
PMID: 7354638 Published · ppublish English Journal Article

A twenty-year experience with surgical management of carcinoma of the esophagus and gastric cardia.

The Journal of thoracic and cardiovascular surgery ·Vol. 79 ·No. 3 ·1980-03-00 ·Pages 447-52

Griffith JL, Davis JT

Abstract

Twenty years of experience with operative treatment of carcinoma of the esophagus and cardia are reviewed. Of the 513 patients with biopsy-proved malignancy reviewed, 211 (41%) underwent gastroesophagectomy. The hospital mortality rate for the patients operated upon was 12%. The 3 year survival rate was 26% and the 5 year survival rate was 15% for the entire surgical series. Squamous cell carcinomas of the lower third were the most favorable subgroup (25% 5 year survival) and lower third adenocarcinomas the least favorable (8% 5 year survival). Our procedure of choice is a one-stage resection with stomach used to restore continuity. Operative details and perioperative management are reviewed. The single-layer wire technique of anastomosis seems to give acceptably low rates of anastomotic leak (4.2%) and stricture (2.3%). Preoperative radiation was not used in this series.

MeSH Terms
Adenocarcinoma/surgery Adult Aged Carcinoma, Squamous Cell/surgery Cardia/surgery Colon/transplantation Esophageal Achalasia/surgery Esophageal Neoplasms/surgery Esophagoplasty Female Hernia, Hiatal/surgery Humans Male Middle Aged Postoperative Complications/mortality Transplantation, Autologous
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Griffith J L
Davis J T
Article Info
Journal
The Journal of thoracic and cardiovascular surgery
Abbr.
J Thorac Cardiovasc Surg
ISSN
0022-5223
Published
1980-03-00
Pages
447-52
Language
English
Region
United States
NLM ID
0376343
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com